Back
Singular Genomics Systems Vs. Harvard Bioscience Industry Stock Comparison
Buy
69
OMIC
Singular Genomics Systems
Last Price:
23.00
Seasonality Move:
13.28%
Sell
44
HBIO
Harvard Bioscience
Last Price:
2.39
Seasonality Move:
6.31%
Buy
69
Singular Genomics Systems (OMIC)
is a Buy
Is Singular Genomics Systems a Buy, Sell or Hold?
- The current Singular Genomics Systems [OMIC] share price is $23.00. The Score for OMIC is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- OMIC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Harvard Bioscience (HBIO)
is a Sell
Is Harvard Bioscience a Buy, Sell or Hold?
- The current Harvard Bioscience [HBIO] share price is $2.39. The Score for HBIO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- HBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OMIC Stock Price Chart
What is Singular Genomics Systems's stock price today?
-
The Singular Genomics Systems share price today is $23.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OMIC is experiencing buying pressure, which is a positive indicator for future bullish movement.
HBIO Stock Price Chart
What is Harvard Bioscience's stock price today?
-
The Harvard Bioscience share price today is $2.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HBIO is experiencing slight buying pressure.
OMIC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.26 | Buy |
| Relative Strength Index (14 RSI): | 79.8 | Buy |
| Chaikin Money Flow: | 20299 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.61 - 17.41) | Buy |
| Bollinger Bands (100): | (6.58 - 14.5) | Buy |
HBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 44.57 | Sell |
| Chaikin Money Flow: | 13850 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.36 - 2.48) | Sell |
| Bollinger Bands (100): | (2.52 - 3.1) | Sell |
OMIC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.67 | Buy |
| 20-day SMA: | 15.05 | Buy |
| 50-day SMA: | 13.04 | Buy |
| 200-day SMA: | 12.21 | Buy |
| 8-day EMA: | 17.13 | Buy |
| 20-day EMA: | 15.45 | Buy |
| 50-day EMA: | 13.56 | Buy |
| 200-day EMA: | 13.89 | Buy |
HBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.39 | Sell |
| 20-day SMA: | 2.4 | Sell |
| 50-day SMA: | 2.61 | Sell |
| 200-day SMA: | 3.41 | Sell |
| 8-day EMA: | 2.39 | Buy |
| 20-day EMA: | 2.43 | Sell |
| 50-day EMA: | 2.59 | Sell |
| 200-day EMA: | 3.25 | Sell |
Singular Genomics Systems Earnings Growth & OMIC Earnings Dates
- Analysts estimate an earnings increase this quarter of $7.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.48 per share, and an increase next year of $3.17 per share.
Harvard Bioscience Earnings Growth & HBIO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $0.08 per share.
Singular Genomics Systems Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Harvard Bioscience Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||